Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency
about
Immunoproteasome deficiency modifies the alternative pathway of NFκB signalingThe ubiquitin-proteasome system and cardiovascular diseaseImmunoproteasomes: structure, function, and antigen presentationTargeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategiesMice lacking pten in osteoblasts have improved intramembranous and late endochondral fracture healingThe ubiquitin proteasome system and myocardial ischemiaThe ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic miceImmunoproteasome deficiency alters retinal proteasome's response to stressUnexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses.PTEN inhibitors cause a negative inotropic and chronotropic effect in mice.Ischemic preconditioning inhibits mitochondrial permeability transition pore opening through the PTEN/PDE4 signaling pathwayCorneal wound healing is compromised by immunoproteasome deficiency.A novel role for the immunoproteasome in retinal function.Proteome dynamics and proteome function of cardiac 19S proteasomesProteasome functional insufficiency in cardiac pathogenesis.Immunoproteasome deficiency protects in the retina after optic nerve crush.Differential effects of Akt1 signaling on short- versus long-term consequences of myocardial infarction and reperfusion injuryPhosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway.Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10.The role of the ubiquitin proteasome system in ischemia and ischemic tolerance.Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failureIschemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a-Dependent H3K9 Dimethylation.Interference with akt signaling protects against myocardial infarction and death by limiting the consequences of oxidative stress.IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism.The role of the proteasome in heart diseaseHeterogeneous cardiac proteasomes: mandated by diverse substrates?Emerging roles of immunoproteasomes beyond MHC class I antigen processing.
P2860
Q21133685-60A20009-516F-4000-AC0D-F35954593A83Q27021582-D993D383-FD16-48E2-8C81-CC6700A98C0AQ27024527-B92AC91C-00FE-46C1-B056-D2B717826816Q27026951-6B8C9CD1-8D72-4949-B066-C44F2E649751Q27319993-525A4B20-7083-486B-A5CF-B9746CA06B2FQ28280898-8E50F74B-CCF0-4DAC-BE4D-CDC094D80092Q33554497-6836D720-ABEA-4906-AF1A-8A50808C8D26Q33554506-05350EB8-5C6C-4FF5-A3FE-1E530F2D52C7Q33905980-AFDBF1E4-BE5B-43F7-9AAD-29B207F5A796Q34018605-B31C0FE4-2273-4D50-9714-B3CDD584B8C0Q34135115-E34220F7-1F73-4EDD-A04A-C284584C3E23Q34384591-5A9D6CBB-31C8-4E0E-B212-B2C3D0777EEAQ34558225-5374903A-39E4-4131-9849-73EFFBBCA8DBQ34568307-7BFAE272-7107-4BA7-A76E-F4C394055312Q34645657-D248337C-410B-4DBF-AF83-FB27AEEC7897Q34994354-53AA8A2A-B06A-429D-86F4-40834C2CB798Q35601400-2030DB30-B0D5-4203-85BD-438872A9855EQ35610769-65BDB22B-F911-476F-9DD8-49F6BF091DBDQ35660775-7A70DC4B-FD7E-47BE-86C0-68B36D7C91B9Q36005489-BA4AC529-4FBF-436F-B211-B00FD80205C9Q36680922-7A722B04-CFFE-415B-B44B-FA39D7CC468CQ37381217-7427C5EF-1103-462C-AA8E-0D8B28058BBDQ37476517-D202DC6C-4074-49EC-A927-6AD95504F60DQ37556326-FDF793E6-4BAD-433B-A926-0BB370D84C55Q37677992-E7BFE726-72A5-4CB9-99FE-E5B847312354Q37727601-CAEB772D-587E-4D0D-92D2-8CB559631C43Q37788836-806CFA7E-8071-468B-9052-9E0BAACFD865Q37864471-54BE0244-ACFC-45EC-93B5-033B3E6D2EA7Q37989860-835D6779-6CAC-460F-A551-D59CF8D8C725
P2860
Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ischemic preconditioning-induc ...... mass polypeptide-2 deficiency
@en
Ischemic preconditioning-induc ...... mass polypeptide-2 deficiency.
@nl
type
label
Ischemic preconditioning-induc ...... mass polypeptide-2 deficiency
@en
Ischemic preconditioning-induc ...... mass polypeptide-2 deficiency.
@nl
prefLabel
Ischemic preconditioning-induc ...... mass polypeptide-2 deficiency
@en
Ischemic preconditioning-induc ...... mass polypeptide-2 deficiency.
@nl
P2093
P2860
P356
P1433
P1476
Ischemic preconditioning-induc ...... mass polypeptide-2 deficiency
@en
P2093
Lewis C Becker
Zhenyun Shen
Zheqing P Cai
P2860
P304
P356
10.1096/FJ.08-105940
P407
P50
P577
2008-08-26T00:00:00Z